Literature DB >> 1442766

Unusual glomerular lesion in a patient receiving long-term interferon alpha.

E Lederer1, L Truong.   

Abstract

A 60-year-old man with long-standing chronic myelogenous leukemia presented with renal insufficiency and proteinuria after more than 6 years of therapy with daily interferon alpha injections. He also manifested unusual skin lesions and a low-titer antinuclear antibody (ANA). Percutaneous renal biopsy disclosed an unusual glomerular lesion characterized by global, diffuse, and marked widening of the lamina rara interna, and focal segmental mesangial proliferation. Discontinuation of the drug resulted in resolution of the proteinuria, but not the renal insufficiency. These glomerular changes have not been reported previously as a complication of this form of malignancy and are similar to lesions reported in newborn rats and mice receiving interferon alpha. The potential role of interferon alpha in the development of this glomerular disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442766     DOI: 10.1016/s0272-6386(12)70268-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.

Authors:  D F Stein; A Ahmed; V Sunkhara; W Khalbuss
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Renal adverse effects of interferon-alpha.

Authors:  Slobodan Jankovic
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.

Authors:  Mehmet Enes Coskun; Sue Height; Anil Dhawan; Nedim Hadzic
Journal:  BMJ Case Rep       Date:  2017-07-14

Review 4.  Interferon-induced acute renal failure: a case report and literature review.

Authors:  R Horowitz; D Glicklich; L B Sablay; P H Wiernik; S Wadler
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

5.  Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes.

Authors:  W Coers; J T Vos; P H Van der Meide; M L Van der Horst; S Huitema; J J Weening
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

Review 6.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 7.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.